The Impact of Medication Belief on Adherence to Infliximab in Patients With Crohn's Disease
NCT ID: NCT05777616
Last Updated: 2023-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
166 participants
OBSERVATIONAL
2021-11-15
2021-12-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaccination Practices for Inflammatory Bowel Disease Patients in China With Gastroenterologists
NCT04948723
The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients
NCT01916161
Adherence to Exclusive Enteral Nutrition in Patients With Crohn's Disease
NCT04933214
Effect of Anti-inflammatory Diet in Patients With Inflammatory Bowel Disease
NCT06342011
Effect of Incentive Integrated E-IBD Chronic Disease Management Model on the Quality of Life in IBD Patients
NCT05719766
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yan Chen
Role: STUDY_DIRECTOR
2nd Affiliated Hospital, School of Medicine, Zhejiang University,China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2ndAffiliated Hospital, School of Medicine, Zhejiang University, China
Zhejiang, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-0592
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.